ArticleCancer management and research2026

Toxic Epidermal Necrolysis in a Patient with Hepatocellular Carcinoma Receiving Pembrolizumab Plus Regorafenib: A Case Report.

Li Ye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.